跳至主要内容
临床试验/NCT07180641
NCT07180641已完成不适用

REGISTRO NACIONAL DE METÁSTASIS HEPÁTICAS DE CÁNCER NO COLORRECTAL

Clinica Universidad de Navarra, Universidad de Navarra0 个研究点目标入组 1,039 人开始时间: 2010年1月1日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,039
主要终点
Overall Survival

研究概览

简要总结

The investigators designed this observational, retrospective, multicenter study including all patients who underwent surgery for non-colorectal liver metastases between January 2010 and December 2022, with the aim of establishing a series of recommendations for the treatment of liver metastases from various extrahepatic primary tumors

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients scheduled for liver surgery due to non-colorectal liver metastases, regardless of the primary tumor origin, via open or minimally invasive approach

排除标准

  • Patients undergoing surgery for colorectal liver metastases, emergency surgical interventions and patients younger than 18 years old.

结局指标

主要结局

Overall Survival

时间窗: 5 years from liver resection

Time from the date of liver resection for non-colorectal metastases to death from any cause. Survival will be assessed for up to 5 years postoperatively

Progression-Free Survival

时间窗: 5 years from surgery

Time from the date of liver resection for non-colorectal metastases to the date of documented disease progression or death from any cause, whichever occurs first. Patients without progression or death will be censored at the last follow-up

次要结局

  • Postoperative Morbidity Rate(90 days from surgery)
  • Postoperative Mortality Rate(90 days from surgery)
  • Recurrence Pattern(Up to 5 years from liver resection)
  • Length of hospital stay(Perioperative/Periprocedural)
  • R0 Resection Rate(At surgery)

研究者

发起方
Clinica Universidad de Navarra, Universidad de Navarra
申办方类型
Other
责任方
Sponsor

相似试验